Palomar vs. Candela: Laser Battle Heats Up
A Texas jury has found that Palomar’s products do not infringe on a Candela patent. Candela had accused eight Palomar handpieces of infringing on three […]
2008 European MedTech Summit
The 2008 European MedTech Summit, taking place in Switzerland on November 19-20th, will highlight 25 of the most promising European MedTech companies. The Summit provides […]
STAAR Surgical: Visian ICL Revenues Grow Despite “LASIK Recession”
STAAR Surgical said Monday that sales of its Visian ICL increased 52% this quarter. In the U.S., Visian sales increased approximately 25% as compared to […]
WebMD Faces New Competition from Waterfront Media, Revolution Health Merger
Waterfront Media and Revolution Health have signed a definitive merger agreement. Waterfront’s Everyday Health Network will now include RevolutionHealth.com and the Revolution Health Network. The […]
Natus Medical’s Continued Commitment to Growth: Acquires NeuroCom International
In a move that underscores the Natus Medical’s continued commitment to growth, the company has acquired privately held NeuroCom International for $18 million. NeuroCom develops […]
Strong Showing at AngioDynamics Despite Diomed Baggage
The AP has a tendency to turn any earnings misstep into a headline. Such was the case with yesterday’s news that “AngioDynamics 1Q profit slips […]
With FDA Clearance, Cepheid Expands Market for its MRSA Diagnostic
In July, Cepheid reported $42.1 million in second quarter revenues, a 55% jump from the $27.2 million reported in Q2 2007. Growth was been driven […]
SyntheMed Raises $4 Million
SyntheMed closed on a $4.0 million private placement today. Investors were issued 10 million shares valued at $0.40 each plus 10 million three-year warrant entitling […]
[AdvaMed 2008] Video Roundup
Our in-house dynamo, Claudia Pinzon and the rest of the the talented team at OneMedTV, have been busy compiling a wealth of valuable video content […]
Definiens Collaboration to Add Technological Muscle to Clarient’s Offerings in Personalized Medicine
In a move that could accelerate the growth of the Clarient’s biomarker business, the company announced Friday that, with Definiens, it will develop and commercialize […]